Labs in Court

Subscribe today for access to
Articles and Reports

By Danielle Sloane, Morgan Tandy | Oct 28, 2024 | 1 min read

Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance

Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation

By Karen Lovitch, Jane Haviland | Jul 24, 2024 | 1 min read

COVID-19-related schemes dominated recent enforcement efforts, which include a national healthcare fraud enforcement action

The posts you requested could not be found. Try changing your module settings or create some new posts.